Ephrem Huaibe
FDA investigator
Appears on 1 document from 2024, mostly at sites in China. Most often cites general requirements (21 CFR 211.180).
- 1
- Documents on file
- 1.0
- Observations per 483
- 2024
- First seen
- 2024
- Most recent
What they cite most
From 1 observations- 21 CFR 211.180General requirements1
Activity by year
2024: 1
Where
China 1
Is Ephrem Huaibe coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2024-03-22 | 483 Sunshine Lake Pharma Co., Ltd.Mar 22, 2024 · Dongguan, China | Dongguan, China | 1 |
About this profile
What does Ephrem Huaibe inspect?
Ephrem Huaibe appears on 1 document on file covering 1 site, mostly in China.
What do they cite most often?
21 CFR 211.180 (general requirements).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Ephrem Huaibe is dated Mar 22, 2024.